Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

229 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cancer incidence in Iran in 2014: Results of the Iranian National Population-based Cancer Registry.
Roshandel G, Ghanbari-Motlagh A, Partovipour E, Salavati F, Hasanpour-Heidari S, Mohammadi G, Khoshaabi M, Sadjadi A, Davanlou M, Tavangar SM, Abadi H, Asgari A, Behrooz M, Cheraghi M, Danechin L, Dolatkhah R, Enferadi F, Esshaghi S, Farahani M, Farrokhzad S, Fateh M, Vahedi S, Golpazir A, Hasanzadeh M, Hazar N, Hoseini-Hoshyar H, Izadi M, Jafarnia A, Jahantigh M, Jalilvand A, Jazayeri M, Joola P, Kazemzadeh Y, Khalednejad M, Kooshki M, Madani A, Malekpour-Afshar R, Bayat AH, Moinfar Z, Mohamadifar H, Mohamadzadeh G, Motidost-Komleh R, Narooei M, Niksiar S, Pirnejad H, Poornajaf A, Pourshahi G, Rahnama A, Rashidpour B, Ravankhah Z, Rezaei K, Rezaeianzadeh A, Sadeghi G, Shahdadi A, Shahi M, Sharafi Z, Sharifi-Moghadam F, Soleimani A, Soltany-Hojatabad M, Tahmasebi Z, Yadolahi S, Yaghoubi-Ashrafi M, Zandian H, Zareiyan A, Poustchi H, Zendehdel K, Ostovar A, Janbabaei G, Reisi A, Malekzadeh R. Roshandel G, et al. Among authors: izadi m. Cancer Epidemiol. 2019 Aug;61:50-58. doi: 10.1016/j.canep.2019.05.009. Epub 2019 May 25. Cancer Epidemiol. 2019. PMID: 31132560
Cancer in Iran 2008 to 2025: Recent incidence trends and short-term predictions of the future burden.
Roshandel G, Ferlay J, Ghanbari-Motlagh A, Partovipour E, Salavati F, Aryan K, Mohammadi G, Khoshaabi M, Sadjadi A, Davanlou M, Asgari F, Abadi H, Aghaei A, Ahmadi-Tabatabaei SV, Alizadeh-Barzian K, Asgari A, Asgari N, Azami S, Cheraghi M, Enferadi F, Eslami-Nasab M, Fakhery J, Farahani M, Farrokhzad S, Fateh M, Ghasemi A, Ghasemi-Kebria F, Gholami H, Golpazir A, Hasanpour-Heidari S, Hazar N, Hoseini-Hoshyar H, Izadi M, Jahantigh M, Jalilvand A, Jazayeri SM, Kazemzadeh Y, Khajavi M, Khalednejad M, Khanloghi M, Kooshki M, Madani A, Mirheidari M, Mohammadifar H, Moinfar Z, Mojtahedzadeh Y, Morsali A, Motidost-Komleh R, Mousavi T, Narooei M, Nasiri M, Niksiar S, Pabaghi M, Pirnejad H, Pournajaf A, Pourshahi G, Rahnama A, Rashidpoor B, Ravankhah Z, Rezaei K, Rezaianzadeh A, Sadeghi G, Salehifar M, Shahdadi A, Shahi M, Sharifi-Moghaddam F, Sherafati R, Soleimani A, Soltany-Hojatabad M, Somi MH, Yadolahi S, Yaghoubi-Ashrafi M, Zareiyan A, Poustchi H, Zendehdel K, Ostovar A, Janbabaei G, Raeisi A, Weiderpass E, Malekzadeh R, Bray F. Roshandel G, et al. Among authors: izadi m. Int J Cancer. 2021 Aug 1;149(3):594-605. doi: 10.1002/ijc.33574. Epub 2021 Apr 21. Int J Cancer. 2021. PMID: 33884608 Free article.
The Iranian blood pressure measurement campaign, 2019: study protocol and preliminary results.
Ostovar A, Sepanlou S, Shariati M, Mahdavi Hezaveh A, Yousefi E, Hodjatzadeh A, Afkar M, Pariani A, Moghisi A, Khalagi K, Najmi M, Bashti S, Aghamohammadi S, Bagherzade Yazdi M, Atefi A, Joneidi A, Barakati H, Heshmat R, Peykari N, Ranjbar M, Hammelman C, Mendis S, Pariyanzeitooni M, Mohammadi N, Noemani K, Barati H, Alborzinia R, Mirshfiee P, Khaligh N, Anvari M, Morsali A, Shirzadian A, Hasani M, Zakeri M, Alizadeh Barzian K, Azadmehr H, Ghasemi A, Delshad A, Hajiuni R, Shafieinia MA, Dolatabad M, Soltani M, Azizi A, Izadi M, Rokhshad H, Sadeghi G, Rahmani MH, Sedaghat SM, Sadeghzade H, Mirmoieni R, Golmohammadi A, Najafi Moghadam T, Ehsanzadeh A, Parvin A, Ahmadian M, Hosseinkhani R, Shadmand S, Shahrokhi F, Panje Shahi M, Shafiei Bafti M, Shahabadi S, Shaddel S, Bayat Asghari A, Talebi E, Sharafi S, Kooshki M, Asadiyan F, Sadeghi MJ, Eghbali B, Norouzinezhad G, Farrokhzad S, Mirheidari M, Nejadghaderi M, Iran Nezhad N, Mehri SM, Rahimzadeh A, Etminanbakhsh H, Dalili A, Aminforghani H, Rahbar MN, Rostampour S, Fateh M, Moradi F, Mousavi SA, Pourabazari G, Sharbafi J, Aminmanesh A, Karimi A, Sarbazi M, Farbakhsh F, Alinezhad J, Parishan Kordiani T, Dalili N, Parisay Z, Sa… See abstract for full author list ➔ Ostovar A, et al. Among authors: izadi m. J Diabetes Metab Disord. 2022 Nov 11;22(1):899-911. doi: 10.1007/s40200-022-01126-9. eCollection 2023 Jun. J Diabetes Metab Disord. 2022. PMID: 37255819 Free PMC article.
Bortezomib exerts its anti-cancer activity through the regulation of Skp2/p53 axis in non-melanoma skin cancer cells and C. elegans.
Prabhu KS, Ahmad F, Kuttikrishnan S, Leo R, Ali TA, Izadi M, Mateo JM, Alam M, Ahmad A, Al-Shabeeb Akil AS, Bhat AA, Buddenkotte J, Pourkarimi E, Steinhoff M, Uddin S. Prabhu KS, et al. Among authors: izadi m. Cell Death Discov. 2024 May 9;10(1):225. doi: 10.1038/s41420-024-01992-7. Cell Death Discov. 2024. PMID: 38724504 Free PMC article.
Effect of high-dose Spirulina supplementation on hospitalized adults with COVID-19: a randomized controlled trial.
Aghasadeghi MR, Zaheri Birgani MA, Jamalimoghadamsiyahkali S, Hosamirudsari H, Moradi A, Jafari-Sabet M, Sadigh N, Rahimi P, Tavakoli R, Hamidi-Fard M, Bahramali G, Parmoon Z, Arjmand Hashjin S, Mirzajani G, Kouhkheil R, Roshangaran S, Khalaf S, Khademi Nadoushan M, Gholamiyan Yousef Abad G, Shahryarpour N, Izadi M, Zendedel A, Jahanfar S, Dadras O, SeyedAlinaghi S, Hackett D. Aghasadeghi MR, et al. Among authors: izadi m. Front Immunol. 2024 Apr 8;15:1332425. doi: 10.3389/fimmu.2024.1332425. eCollection 2024. Front Immunol. 2024. PMID: 38655258 Free PMC article. Clinical Trial.
229 results